NCT06057168 2026-01-29
GDX-44-016
Guerbet
Phase 3 Completed
Clinical Trials
10 trialsNCT04373564 2026-01-22
ODYSSEY
Guerbet
Phase 4 Recruiting
NCT05937776 2025-11-10
Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas
OHSU Knight Cancer Institute
Recruiting
NCT01514617 2024-07-10
Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization
Universitaire Ziekenhuizen KU Leuven
Phase NA Active not recruiting
NCT04341129 2023-12-05
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
University of Chicago
Phase EARLY_PHASE1 Completed
NCT03091803 2021-04-05
QSM and Regional DCE MRI Permeability Using GOCART Technique
University of Southern California
Withdrawn
NCT01806740 2019-08-08
DCE-MRI
Guerbet
Phase 4 Terminated
NCT02034708 2016-12-30
REMIND
Guerbet
Phase 4 Completed
NCT03000036 2016-12-21
Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
University of Campinas, Brazil
Phase NA Completed
NCT01657747 2015-07-02
S53580
Universitaire Ziekenhuizen KU Leuven
Phase NA Completed